| FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | |||||||||||||||||
| Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. | |||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
LUXFER HOLDINGS PLC [ LXFR ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
|
3. Date of Earliest Transaction
(Month/Day/Year) 06/09/2025 | ||||||||||||||||||||||||||
|
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Ordinary Shares | 06/09/2025 | M | 800 | A | (1) | 23,422 | D | |||
| Ordinary Shares | 06/09/2025 | M | 128 | A | (2) | 23,550 | D | |||
| Ordinary Shares | 06/09/2025 | M | 1,000 | A | (1) | 24,550 | D | |||
| Ordinary Shares | 06/09/2025 | M | 125 | A | (2) | 24,675 | D | |||
| Ordinary Shares | 06/09/2025 | M | 2,304 | A | (1) | 26,979 | D | |||
| Ordinary Shares | 06/09/2025 | M | 900 | A | (1) | 27,879 | D | |||
| Ordinary Shares | 06/09/2025 | M | 1,070 | A | (1) | 28,949 | D | |||
| Ordinary Shares | 06/09/2025 | M | 92 | A | (2) | 29,041 | D | |||
| Ordinary Shares | 06/09/2025 | M | 1,790 | A | (1) | 30,831 | D | |||
| Ordinary Shares | 06/09/2025 | M | 75 | A | (2) | 30,906 | D | |||
| Ordinary Shares | 06/09/2025 | S | 4,244 | D | $11.83 | 26,662 | D | |||
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Stock Options (Right to Buy) | (1) | 06/09/2025 | M | 800 | (3) | 03/15/2027 | Ordinary Shares | 800 | (1) | 0 | D | ||||
| Dividend Equivalent Rights | (2) | 06/09/2025 | M | 128 | (2) | 03/15/2027 | Ordinary Shares | 128 | (2) | 0 | D | ||||
| Stock Options (Right to Buy) | (1) | 06/09/2025 | M | 1,000 | (4) | 03/14/2028 | Ordinary Shares | 1,000 | (1) | 1,000 | D | ||||
| Dividend Equivalent Rights | (2) | 06/09/2025 | M | 125 | (2) | 03/14/2028 | Ordinary Shares | 125 | (2) | 144 | D | ||||
| Stock Options (Right to Buy) | (1) | 06/09/2025 | M | 2,304 | (5) | 03/14/2027 | Ordinary Shares | 2,304 | (1) | 0 | D | ||||
| Stock Options (Right to Buy) | (1) | 06/09/2025 | M | 900 | (6) | 03/14/2027 | Ordinary Shares | 900 | (1) | 0 | D | ||||
| Stock Options (Right to Buy) | (1) | 06/09/2025 | M | 1,070 | (7) | 03/20/2029 | Ordinary Shares | 1,070 | (1) | 2,140 | D | ||||
| Dividend Equivalent Rights | (2) | 06/09/2025 | M | 92 | (2) | 03/20/2029 | Ordinary Shares | 92 | (2) | 236 | D | ||||
| Stock Options (Right to Buy) | (1) | 06/09/2025 | M | 1,790 | (8) | 03/18/2030 | Ordinary Shares | 1,790 | (1) | 5,370 | D | ||||
| Dividend Equivalent Rights | (2) | 06/09/2025 | M | 75 | (2) | 03/18/2030 | Ordinary Shares | 75 | (2) | 230 | D | ||||
| Explanation of Responses: |
| 1. 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. |
| 2. Represents dividend equivalent rights accrued on employee Stock Options, which become exercisable proportionately with the Stock Options to which they relate. Each dividend equivalent right is the economic equivalent of one Ordinary Share. The subject dividend equivalent rights convert 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. |
| 3. Represents the exercise of time-based Stock Options awarded on March 15, 2021. The subject Stock Options vested and were exercisable as of March 15, 2025. |
| 4. Represents the exercise of time-based Stock Options awarded on March 14, 2022. The subject Stock Options vested and were exercisable as of March 14, 2025. The remaining Stock Options vest and become exercisable on March 14, 2026. |
| 5. Represents the exercise of performance-based Stock Options (at 96% target) awarded on March 14, 2022. 100% of the performance-based Stock Options vested on March 14, 2025 upon the achievement of Earnings Per Share (EPS) Growth goals for the three-year performance period ended December 31, 2024. |
| 6. Represents the exercise of performance-based Stock Options (at 25% target) awarded on March 14, 2022. 100% of the performance-based Stock Options vested on March 14, 2025 upon the achievement of Total Shareholder Return (TSR) goals for the three-year performance period ended December 31, 2024. |
| 7. Represents the exercise of time-based Stock Options awarded on March 20, 2023. The subject Stock Options vested and were exercisable as of March 20, 2025. The remaining Stock Options vest in two equal annual instalments beginning on March 20, 2026 |
| 8. Represents the exercise of time-based Stock Options awarded on March 18, 2024. The subject Stock Options vested and were exercisable as of March 18, 2025. The remaining Stock Options vest in three equal annual instalments beginning on March 18, 2026. |
| Remarks: |
| /s/ Benjamin Coulson under Power of Attorney for Stephen Webster | 06/11/2025 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||